JKN-2301

N/A

Report date: 2026/02/12 20:00:14
NME

Base Information

Drug NameJKN-2301
Drug Alias Name玛帕西沙韦干混悬剂JKN2301JKN-2301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase acidic protein inhibitors
TargetsPolymerase acidic protein
Therapy Area/IndicationsInfluenza A virus infectionsRespiratory Tract InfectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsRespiratory Tract InfectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A